Sodium Polystyrene Sulfonate
- Product NDC
- 51293-831
- 11-digit product format
- 512930831
- Labeler code
- 51293
- Product ID
- 51293-831_111a8f39-8fd1-41e2-a324-6efa3c3b1e3a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sodium Polystyrene Sulfonate
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL; RECTAL
- Labeler
- ECI Pharmaceuticals, LLC
- Application
- ANDA090313
- Marketing category
- ANDA
- Marketing start
- 2017-02-07
- Marketing end
- 0000-00-00
- Substance
- SODIUM POLYSTYRENE SULFONATE
- Active strength
- 4 meq/g
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51293-831-97 | 2026-01-22 | C162847 | 48780-1 | d6a99b39-e882-a426-e053-dadaa90af4c2 | 024b9f0b-42f0-42dd-ac2b-b46e15e45440 |
| 51293-831-97 | 2024-01-30 | C162847 | 48780-1 | d6a99b39-e882-a426-e053-dadaa90af4c2 | 024b9f0b-42f0-42dd-ac2b-b46e15e45440 |
| 51293-831-97 | 2022-03-03 | C162847 | 48780-1 | d6a99b39-e882-a426-e053-dadaa90af4c2 | 024b9f0b-42f0-42dd-ac2b-b46e15e45440 |
| 51293-831-97 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-e882-a426-e053-dadaa90af4c2 | 024b9f0b-42f0-42dd-ac2b-b46e15e45440 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51293-831-97 | GM - Gram | 51293-831 | 91a16338-505e-47f5-a556-38bee5d58030 | 1 | 2018-03-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2101899 | sodium polystyrene sulfonate 15 GM Powder for Suspension | PSN | af0a64e1-4fde-4320-93a7-7801a03b7613 | 4 |
| 2101899 | sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension | SCD | af0a64e1-4fde-4320-93a7-7801a03b7613 | 4 |
| 2101899 | sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension | SY | af0a64e1-4fde-4320-93a7-7801a03b7613 | 4 |
| 2101899 | sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension | SY | af0a64e1-4fde-4320-93a7-7801a03b7613 | 4 |
| 2101899 | sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension | SY | af0a64e1-4fde-4320-93a7-7801a03b7613 | 4 |
| 2101899 | sodium polystyrene sulfonate 15 GM Powder for Suspension | PSN | 806b330b-6564-41c9-a87c-2d68a42e696a | 1 |
| 2101899 | sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension | SCD | 806b330b-6564-41c9-a87c-2d68a42e696a | 1 |
| 2101899 | sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension | SY | 806b330b-6564-41c9-a87c-2d68a42e696a | 1 |
| 2101899 | sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension | SY | 806b330b-6564-41c9-a87c-2d68a42e696a | 1 |
| 2101899 | sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension | SY | 806b330b-6564-41c9-a87c-2d68a42e696a | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51293-831-97 | 51293083197 | 453.6 g in 1 JAR (51293-831-97) | 453.6 g | 2017-02-07 | 0000-00-00 | No | No | Current |